News

Technology News

Natera Reveals Prenatal Diagnostic Test Info

Monday, February 6, 2012 5:01:00 AM PDT | VentureDeal Staff
Redwood City, California  --  Diagnostic company Natera announced that it will present at the upcoming Society for Maternal-Fetal Medicine Annual Meeting.

Natera is currently in clinical trial evaluation stage for its non-invasive prenatal diagnostic test.

The test promises to detect multiple disorders, including Edwards syndrome, Down syndrome, Patau syndrome and other chromosome abnormalities.

The company says that its test is different in that it will provide detection coverage comparable to invasive tests.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1